Clinical Trial Update: Rhinovirus Study With Lactobacillus Rhamnosus GG [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Lactobacillus rhamnosus GG for rhinovirus-related respiratory tract infections has completed, sponsored by Valio Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• Lactobacillus rhamnosus GG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Valio Ltd | Conditions: Respiratory Tract Infections [C08.730] | Phase 4 | Status: COMPLETED